RFK Jr.’s COVID Vaccine Restrictions Spark Outrage
The FDA has granted full approval to the Novavax COVID-19 vaccine, but with significant limitations. Access will be restricted to individuals aged 12 and older with pre-existing conditions putting them at high risk of severe COVID-19. This decision, impacting healthy adults and raising concerns about future variant protection, has drawn criticism for potentially reflecting the influence of vaccine skepticism within the administration. The restricted availability contrasts with the full approval granted to Pfizer-BioNTech and Moderna vaccines in 2022.
John Q. Hosedrinker